Literature DB >> 15546306

Relationship of baseline electrocardiographic characteristics with the response to cardiac resynchronization therapy for heart failure.

Matthew R Reynolds1, Lilian P Joventino, Mark E Josephson.   

Abstract

Prospective identification of patients most and least likely to respond to cardiac resynchronization therapy (CRT) for congestive heart failure (CHF) will allow clinicians to target this intervention most efficiently. The authors hypothesized that ECG variables including RBBB and indicators of RV dysfunction and extensive prior myocardial infarction would correlate with diminished response to CRT. This study analyzed preimplantation ECGs in 110 patients with ICD indications and CHF due to left ventricular systolic dysfunction randomized to active biventricular pacing in the MIRACLE ICD trial. Clinical and ECG variables on the outcome of change in peak oxygen consumption from baseline to 6 months (Delta-VO2 ) were evaluated. For this cohort, average peak VO2 improved from 13.4 to 14.3 mL/kg per minute. Among clinical variables, the strongest predictors of increasing Delta-VO2 were reduced exercise time and peak VO2 at baseline. A dominant R wave in lead a VR, RBBB, and evidence of prior anterior infarction were each associated with significantly smaller average improvements in Delta-VO2 than their absence in univariate analysis. Alternative ECG criteria, including QRS duration, had no relationship with the outcome. In a multivariate model, only baseline VO2 (beta=-0.3, P=0.001) and ECG evidence of prior anterior infarction (beta=-1.3, P=0.03) were associated with the outcome. ECG markers of anterior infarction and RV dilation may help identify CHF patients unlikely to benefit from biventricular pacing. Further assessment is needed of these and other predictors of therapeutic response to CRT.

Entities:  

Mesh:

Year:  2004        PMID: 15546306     DOI: 10.1111/j.1540-8159.2004.00669.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  5 in total

1.  Utility of three-dimensional echocardiography in assessing and predicting response to cardiac resynchronization therapy.

Authors:  Ching Lau; Husam Mohamed Abdel-Qadir; Ilan Lashevsky; Mark Hansen; Eugene Crystal; Campbell Joyner
Journal:  Can J Cardiol       Date:  2010-11       Impact factor: 5.223

2.  Novel measure of electrical dyssynchrony predicts response in cardiac resynchronization therapy: Results from the SMART-AV Trial.

Authors:  Larisa G Tereshchenko; Alan Cheng; Jason Park; Nicholas Wold; Timothy E Meyer; Michael R Gold; Suneet Mittal; Jagmeet Singh; Kenneth M Stein; Kenneth A Ellenbogen
Journal:  Heart Rhythm       Date:  2015-08-10       Impact factor: 6.343

3.  Relation of QRS shortening to cardiac output during temporary resynchronization therapy after cardiac surgery.

Authors:  Matthew E Spotnitz; Marc E Richmond; Thomas Alexander Quinn; Santos E Cabreriza; Daniel Y Wang; Catherine M Albright; Alan D Weinberg; José M Dizon; Henry M Spotnitz
Journal:  ASAIO J       Date:  2010 Sep-Oct       Impact factor: 2.872

Review 4.  Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events.

Authors:  Naomi D Herz; Joseph Engeda; Robbert Zusterzeel; William E Sanders; Kathryn M O'Callaghan; David G Strauss; Samantha B Jacobs; Kimberly A Selzman; Ileana L Piña; Daniel A Caños
Journal:  J Womens Health (Larchmt)       Date:  2015-03-20       Impact factor: 2.681

5.  Left Axis Deviation in Patients with Acute Heart Failure with Left Bundle Branch Block: Does It Really Matter?

Authors:  Eue Keun Choi
Journal:  Korean Circ J       Date:  2018-11       Impact factor: 3.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.